JP2023550480A5 - - Google Patents
Info
- Publication number
- JP2023550480A5 JP2023550480A5 JP2023530809A JP2023530809A JP2023550480A5 JP 2023550480 A5 JP2023550480 A5 JP 2023550480A5 JP 2023530809 A JP2023530809 A JP 2023530809A JP 2023530809 A JP2023530809 A JP 2023530809A JP 2023550480 A5 JP2023550480 A5 JP 2023550480A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- hpv6
- vector
- polynucleotide according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118222P | 2020-11-25 | 2020-11-25 | |
| US63/118,222 | 2020-11-25 | ||
| PCT/US2021/060605 WO2022115470A1 (en) | 2020-11-25 | 2021-11-23 | Human papilloma virus vaccines and uses of the same for hpv associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550480A JP2023550480A (ja) | 2023-12-01 |
| JP2023550480A5 true JP2023550480A5 (https=) | 2024-12-02 |
Family
ID=81754898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530809A Pending JP2023550480A (ja) | 2020-11-25 | 2021-11-23 | ヒト乳頭腫ウイルスワクチンおよびｈｐｖ関連疾患のための同ワクチンの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240173396A1 (https=) |
| EP (1) | EP4251278A4 (https=) |
| JP (1) | JP2023550480A (https=) |
| KR (1) | KR20230113331A (https=) |
| CN (1) | CN117203342A (https=) |
| AU (1) | AU2021385551A1 (https=) |
| CA (1) | CA3197920A1 (https=) |
| IL (1) | IL303113A (https=) |
| MX (1) | MX2023006038A (https=) |
| WO (1) | WO2022115470A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121752584A (zh) * | 2023-05-22 | 2026-03-27 | 普瑞赛格恩公司 | 用于治疗复发性呼吸道乳头状瘤病的新型腺病毒疫苗疗法 |
| EP4716549A2 (en) * | 2023-05-22 | 2026-04-01 | Precigen, Inc. | T cell receptors generated as a result of hpv vaccine therapy and methods of treating patients with same |
| CN117965634B (zh) * | 2024-04-01 | 2024-07-12 | 北京唯源立康生物科技股份有限公司 | 一种hsv-1病毒载体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| ES2276948T3 (es) * | 2001-08-23 | 2007-07-01 | MERCK & CO., INC. | Ensayos pcr de hp multiplex fluorescente que usan fluoforos multiples. |
| GB0222953D0 (en) * | 2002-10-03 | 2002-11-13 | Glaxo Group Ltd | Novel Compounds |
| AU2005222776A1 (en) * | 2003-12-31 | 2005-09-29 | Genimmune N.V. | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| US9050287B2 (en) * | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
| MX360449B (es) * | 2011-10-12 | 2018-11-01 | Univ Pennsylvania | Vacunas para el virus del papiloma humano y metodos para su uso. |
| WO2018060288A1 (en) * | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| KR102222582B1 (ko) * | 2018-02-02 | 2021-03-04 | 주식회사 에스엘백시젠 | 신규 다가 hpv 백신 조성물 |
| KR20250136930A (ko) * | 2018-03-06 | 2025-09-16 | 프레시전 인코포레이티드 | 사람 파필로마바이러스 백신 및 이의 용도 |
-
2021
- 2021-11-23 JP JP2023530809A patent/JP2023550480A/ja active Pending
- 2021-11-23 CA CA3197920A patent/CA3197920A1/en active Pending
- 2021-11-23 EP EP21899044.8A patent/EP4251278A4/en active Pending
- 2021-11-23 AU AU2021385551A patent/AU2021385551A1/en active Pending
- 2021-11-23 IL IL303113A patent/IL303113A/en unknown
- 2021-11-23 MX MX2023006038A patent/MX2023006038A/es unknown
- 2021-11-23 KR KR1020237020302A patent/KR20230113331A/ko active Pending
- 2021-11-23 US US18/253,624 patent/US20240173396A1/en active Pending
- 2021-11-23 CN CN202180089584.2A patent/CN117203342A/zh active Pending
- 2021-11-23 WO PCT/US2021/060605 patent/WO2022115470A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023550480A5 (https=) | ||
| JP2022160401A (ja) | Ｈｐｖワクチン | |
| JP3056502B2 (ja) | ヒトパピローマウイルス１６型のｅ７タンパク質上の免疫原性領域 | |
| RU2462513C2 (ru) | Векторы для множественной генной экспрессии | |
| CN101426811A (zh) | 基于hpv-16的乳头瘤病毒疫苗 | |
| CN101426810A (zh) | 基于hpv-18的乳头瘤病毒疫苗 | |
| US9249193B2 (en) | Truncated L1 protein of human papillomavirus type 33 | |
| IL215599A (en) | A nucleic acid-encoding vector for proteins 1e and 2e of the papilloma virus | |
| JP2018518172A5 (https=) | ||
| JP2012509678A5 (https=) | ||
| WO2024169804A1 (zh) | 一种基于Tac启动子的质粒表达载体构建及其用途 | |
| WO2014103608A1 (ja) | HPV/HBsキメラタンパク質を有効成分とするHPV感染症及び／又はＢ型肝炎用ワクチン | |
| JP2024544566A5 (https=) | ||
| HRP20250701T1 (hr) | Himerni protein papiloma virusa l1 | |
| JP2019502404A5 (https=) | ||
| Gissmann et al. | Therapeutic vaccines for human papillomaviruses | |
| CN101952320B (zh) | 具有免疫原性的物质 | |
| JP6863966B2 (ja) | 標的ポリペプチドを提示するためのポリペプチド担体及びその使用 | |
| US6991795B1 (en) | Protein delivery system using human papillomavirus virus-like particles | |
| CN114127092B (zh) | 人乳头瘤病毒多价免疫原性组合物 | |
| CN102311500A (zh) | 一种抗病毒融合蛋白及其应用 | |
| US20160200776A1 (en) | Truncated L1 Protein of Human Papillomavirus Type 58 | |
| JP4563582B2 (ja) | ヒトパピローマウイルスのウイルス様粒子を使用するタンパク質送達系 | |
| JP2012501351A5 (https=) | ||
| CN105801704A (zh) | 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用 |